These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15727498)

  • 1. Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity.
    Greenwald MK
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):3-14. PubMed ID: 15727498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation.
    Greenwald MK; Roehrs TA
    Neuropsychopharmacology; 2005 Jan; 30(1):212-21. PubMed ID: 15508021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations.
    Greenwald MK
    Exp Clin Psychopharmacol; 2002 Feb; 10(1):39-46. PubMed ID: 11866251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone blocks reinforcement but not motivation in an operant runway model of heroin-seeking behavior.
    McFarland K; Ettenberg A
    Exp Clin Psychopharmacol; 1998 Nov; 6(4):353-9. PubMed ID: 9861549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
    Walsh SL; Nuzzo PA; Babalonis S; Casselton V; Lofwall MR
    Drug Alcohol Depend; 2016 May; 162():190-8. PubMed ID: 27012435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of buprenorphine on fentanyl withdrawal in rats.
    Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
    Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
    Schulteis G; Chiang D; Archer C
    Pharmacol Biochem Behav; 2009 Mar; 92(1):157-63. PubMed ID: 19061911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
    Comer SD; Collins ED
    J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans.
    Greenwald MK; Schuh KJ; Hopper JA; Schuster CR; Johanson CE
    Psychopharmacology (Berl); 2002 Apr; 160(4):344-52. PubMed ID: 11919661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
    Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
    J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dysphoria of heroin addiction.
    Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1992; 18(3):275-87. PubMed ID: 1329491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
    Comer SD; Walker EA; Collins ED
    Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.